Fibulin-3 Antibodies

Santa Cruz Biotechnology features a diverse variety of Fibulin-3 monoclonal antibodies for research focused on understanding this important extracellular matrix protein. Fibulin-3 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fibulin-3, also known as EFEMP1, plays a critical role in tissue organization and cellular signaling, influencing processes such as angiogenesis and wound healing. Research has shown Fibulin-3's involvement in various diseases, including age-related macular degeneration and certain cancers. Understanding Fibulin-3's molecular mechanisms can provide insights into disease progression and potential therapeutic approaches. Researchers worldwide utilize Fibulin-3 monoclonal antibodies to explore protein expression, localization, and interactions in various biological systems. Advanced research techniques incorporating Fibulin-3 monoclonal antibodies help reveal new pathways and mechanisms in cellular biology. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific understanding of Fibulin-3's role in health and disease.